Filing Details
- Accession Number:
- 0001209191-20-042504
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-15 17:03:46
- Reporting Period:
- 2020-07-13
- Accepted Time:
- 2020-07-15 17:03:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1610950 | Syneos Health Inc. | SYNH | Services-Commercial Physical & Biological Research (8731) | 273403111 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1624073 | Alistair Macdonald | C/O Syneos Health, Inc. 1030 Sync Street Morrisville NC 27560 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2020-07-13 | 3,655 | $10.57 | 264,809 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2020-07-13 | 3,655 | $58.21 | 261,154 | No | 4 | S | Direct | |
Class A Common Stock | Acquisiton | 2020-07-14 | 5,173 | $10.57 | 266,327 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2020-07-14 | 4,800 | $58.64 | 261,527 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2020-07-14 | 373 | $59.15 | 261,154 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (Right to Buy Class A Common Stock) | Disposition | 2020-07-13 | 3,655 | $0.00 | 3,655 | $10.57 |
Class A Common Stock | Stock Option (Right to Buy Class A Common Stock) | Disposition | 2020-07-14 | 5,173 | $0.00 | 5,173 | $10.57 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,173 | 2017-08-01 | 2022-09-24 | No | 4 | M | Direct |
0 | 2017-08-01 | 2022-09-24 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2020.
- The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $58.00 to $58.37, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $58.13 to $59.12, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.
- The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $59.14 to $59.15, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.